Lunit to deliver AI imaging solutions to Bumrungrad International Hospital

Lunit has partnered with Fujifilm Thailand and Microsoft to convey its AI radiology solutions to Bumrungrad International Hospital, a personal hospital based mostly in Bangkok.

According to a press assertion, Lunit is deploying its chest x-ray evaluation software program INSIGHT CXR and mammography instrument INSIGHT MMG within the hospital.

Together with Fujifilm Thailand, Lunit will provide its AI solutions to Bumrungrad utilizing Microsoft Azure, which the corporate claims will improve the operation of its software program.


Bumrungrad is without doubt one of the largest personal hospitals in Southeast Asia with 580 beds, serving over one million sufferers every year throughout 190 nations.

The hospital goals to present higher companies via its well timed detection of chest abnormalities and breast most cancers utilizing AI.

“AI would be a support tool for human decision-making, providing a second opinion for doctors’ consideration during the diagnostic process,” stated Dr Teeradache Viangteeravat, Bumrungrad’s R&D director.

Presently, the hospital is utilizing the Lunit AI solutions in its check-ups, intensive care models, and emergency rooms. The INSIGHT CXR and INSIGHT MMG have up to now analyzed greater than 100,000 photos taken every year within the hospital.

Bumrungrad additionally expects that the AI ​​solutions will assist “speed up the learning curve for junior doctors with less experience in reading images”.

Lunit stated it plans to help Bumrungrad additional to “drive groundbreaking medical innovation across Southeast Asia”.


Early this 12 months, an analogous deployment deal was signed between Lunit and Egypt-based Bahaya Foundation. The non-profit charity group, which gives free-of-charge take care of breast most cancers sufferers, has adopted the Lunit INSIGHT MMG.

In different information, Lunit not too long ago obtained its chest x-ray and mammography solutions cleared for market launch in Canada. This adopted the approval of the US Food and Drug Administration for a similar AI merchandise final 12 months.

Last month, Lunit filed a registration assertion with the Korean Exchange for an preliminary public providing this July. The firm plans to situation a complete of 1.12 million shares price between $34-$38 apiece.


Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button